Pharmacological inhibition of the ataxia telangiectasia and Rad3-related protein serine/threonine kinase (ATR; also referred to as FRAP-associated protein (FRP1)) has emerged as a promising system for cancer cure that exploits artificial lethal interactions with proteins involved with DNA injury repair service, overcomes resistance to other therapies and boosts antitumour immunity. https://archertfpip.blogoscience.com/32681279/facts-about-gsmtx4-tfa-1209500-46-8-free-base-revealed